Pharma & Biopharma

While pharmaceutical (pharma) and biopharmaceutical (biopharma) share the common goal of improving health outcomes, the two sectors differ significantly in terms of how drugs are developed, manufactured, and marketed..read more

Pharma & Biopharma

The Difference Between Pharma and Biopharma and Their Use of Press Release Distribution in Marketing

The pharmaceutical (pharma) and biopharmaceutical (biopharma) industries play a crucial role in healthcare by developing drugs and therapies to treat…

Read More

Insilico Medicine Raises More Than US$290 Million in Hong Kong’s Largest Biotech IPO of 2025

  News AI-driven drug discovery company Insilico Medicine raised approximately HKD 2.28 billion (more than US$290 million) in its initial public…

Pharma & Biopharma

Novo Nordisk’s weight loss pill approved by FDA

The clearance brings an oral form of Novo’s Wegovy to market ahead of Lilly’s rival medication and kicks off the…

Pharma & Biopharma

Insilico Medicine Files for Hong Kong IPO, Aims to Raise $292M

AI drug developer Insilico Medicine has returned to the Hong Kong public markets with an updated IPO prospectus, targeting about $292…

Pharma & Biopharma

Arcus cancels work on Gilead-partnered cancer combo after trial setback

A study using TIGIT and PD-1 drugs for gastrointestinal disease was canceled for “futility” at an early checkpoint, another blow…

Pharma & Biopharma

Antheia and TAPI Announce Strategic Partnership to Scale Biosynthetic Pharmaceutical Manufacturing

  News Antheia and TAPI have formed a strategic partnership to accelerate global commercialization of Antheia’s biosynthetic manufacturing platform for key…

Pharma & Biopharma

Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3

The layoffs affect Swiss manufacturing facilities. Elsewhere, the FDA pushed back an approval deadline and a mid-stage study showed Novo’s…

Pharma & Biopharma
Show More